Trexquant Investment’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Buy
+73,905
New +$1.48M 0.01% 1135
2025
Q4
Sell
-116,436
Closed -$2.32M 1949
2025
Q3
$2.32M Buy
+116,436
New +$2.09M 0.02% 856
2025
Q2
Sell
-15,454
Closed -$171K 1900
2025
Q1
$171K Sell
15,454
-157,097
-91% -$1.67M ﹤0.01% 1482
2024
Q4
$1.84M Sell
172,551
-99,119
-36% -$1.19M 0.02% 891
2024
Q3
$3.45M Buy
271,670
+190,961
+237% +$2.83M 0.04% 616
2024
Q2
$1.35M Buy
+80,709
New +$1.15M 0.02% 894
2023
Q3
Sell
-14,763
Closed -$153K 1845
2023
Q2
$153K Buy
+14,763
New +$163K ﹤0.01% 1349
2022
Q3
Sell
-30,407
Closed -$249K 1855
2022
Q2
$249K Buy
30,407
+12,211
+67% +$83.9K 0.01% 1223
2022
Q1
$158K Buy
+18,196
New +$142K 0.01% 1239
2021
Q1
Sell
-15,812
Closed -$285K 1485
2020
Q4
$285K Buy
+15,812
New +$331K 0.03% 712

Other funds holding URGN